The Astellas European Foundation has awarded $150,000 under the 2014 Functional Urology and Uro-Gynaecology Grant to Dr Marianne Gamper for conducting a study, which will be undertaken in Austria and Switzerland.
The project will quantify marker levels to identify the potential relationship between overactive bladder syndrome (OAB) and bladder pain syndrome, also known as interstitial cystitis.
Go deeper with GlobalData
The project team represents different centres including Kantonsspital Frauenfeld and ETH Zürich in Switzerland, and Medizinische Universität Graz in Austria.
According to the foundation, the project led by Gamper and the research team has the potential to verify a hypothesis that could lead to improved early diagnosis and more targeted treatment for OAB and bladder pain syndrome/interstitial cystitis patients.
Gamper said the project is designed to identify, quantify, and compare molecular marker levels in patient samples and associate the results with the severity of clinical findings.
“The prize money directly provides the essential financial support for our laboratory work, thereby enabling us to continue our fundamental and important research on debilitating chronic bladder diseases,” Gamper said.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataAwarding the grant, The Astellas European Foundation reiterated its long-term commitment to research and development.
So far, Astellas European Foundation has received 35 research proposals from across Europe.
Entries covered a broad range of topics in functional urology and also those in uro-gynaecology, the foundation said.
The Astellas European Foundation is aimed at providing support for programmes and activities that advance the understanding of medicine and health.
The grant supports basic medical and related scientific programmes which contribute to advancements in urology.
The foundation now provides annual grants of $150,000 for Functional Urology and Uro-Gynaecology, Uro-Oncology and Transplantation.
Image: Representatives at the award presentation. Photo: courtesy of Astellas Pharma Europe.
